Sir, An 82-year-old Japanese woman presented with a 2-year history of a nonhealing ulcer on the left breast without pain or pruritus. There is no history of arsenic exposure. Physical examination revealed a well-demarcated erythematous plaque with erosions on the areola [ Figure 1 ]. Dermoscopic findings showed irregular white reticular structure with various blood vessels [ Figure 2 ]. The skin on the nipple was intact. No palpable lymph nodes (axillary and others) were noted. Histopathological findings revealed pagetoid cells in all layers of the epidermis [ Figure 3 ]. On immunohistochemical staining, the pagetoid cells were positive for CK5/6 and p63 [ Figure 4 ] but negative for CK7, CK20, GCDFP15, PAS, S-100 protein, Melan A, and HMB-45. Therefore, pagetoid Bowen's disease (PBD) was suspected. After the complete excision, the specimen showed more typical areas of Bowen's disease that displayed dyskeratotic cells and multinucleated giant cells in the epidermis [ Figure 5 ]. Immunohistochemistry showed the same findings as Bowen's disease is a form of cutaneous squamous cell carcinoma in situ more commonly developing on sun-exposed sites. Bowen's disease of the breast is extremely rare. With only 9 cases reported in the English literature so far, and none of them is PBD on nipple-areola complex. [1] PBD, in which pagetoid cells are observed histologically, accounts for 5% of Bowen's disease. [2] The pagetoid growth pattern mimics mammary Paget's disease and superficial spreading melanoma. [3] The treatment, surgical margin of excision, and the follow-up period are different, so it is crucial to make the exact diagnosis. Histopathological features for PBD include the existence of dyskeratotic cells, multinucleated giant cells, desmosomes among pagetoid cells, and pagetoid cells existing in all layers of the epidermis. In contrast, pagetoid cells tend to exist only in the lower layer of epidermis in mammary Paget's disease and malignant melanoma. Nevertheless, it is sometimes difficult to differentiate from one another without the help of immunohistochemistry. [4] In PBD, pagetoid cells typically stain for CK 5/6 and p63. GCDFP15 and PAS expression are observed in mammary Paget's disease. S-100 and HMB-45 are useful markers for malignant melanoma. Notably, CK7 expression is almost always observed in mammary Paget's disease. However, cases of PBD with positive CK7 expression have been reported. Although our case shows negative expression for CK7, CK7 expression is not always a helpful marker to differentiate PBD from mammary Paget's disease. [3] Mammary Paget's disease is frequently associated with underlying breast carcinoma, which often originates from lactiferous ducts. [5] Therefore, the clinical lesion usually starts from the nipple, then it extends to the areola and surrounding skin. In contrast, in our case of PBD, the lesion only involved the areola and left the skin of the nipple uninvolved. The clinical appearance without nipple involvement actually gave us a hint that this disease might not arise from the nipple or the underlying lactiferous ducts. Consequently, the existence of clinical nipple involvement can also be a clue to tell the difference between PBD and mammary Paget's disease.
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There are no conflicts of interest. Sir, Myopericytoma was first described by Granter et al. in 1998 as benign tumor showing a myoid/pericytic line of differentiation. [1] It is most commonly found in subcutaneous and deep dermis of distal extremities, but in some cases, superficial dermis is also involved. "Cutaneous myopericytoma" usually occurs as a solitary lesion, although multiple lesions may be seen. [2] In most cases, myopericytoma behaves in a nonaggressive manner and the recurrence has rarely been reported after surgical excision. [2, 3] Histopathologically, myopericytoma is characterized by a well-circumscribed, nodular proliferation with numerous thin-walled blood vessels and a concentric, perivascular arrangement of ovoid spindle-shaped cells with eosinophilic cytoplasm and vesicular nuclei in the dermis, subcutis, or soft tissues. Mitotic activity and cytological atypia is usually minimal. Immunohistochemically, all cases express smooth muscle actin (SMA) and 90% of cases express caldesmon; other smooth muscle markers are negative. [3] Expanding the clinical spectrum of this uncommon benign tumor, we describe a case of cutaneous myopericytoma of the forehead to review its histopathological and immunohistochemical features.
A 44-year-old female presented to our dermatology department with a slow-growing painful red nodule on her forehead. Except for diabetes mellitus, she did not have any underlying disease or any history of trauma. The dermatologic examination showed a 2 cm × 2 cm lesion with an irregular border, violet atrophic, and nodular plaque located in the frontal region [ Figure 1 ]. Our differential diagnosis included discoid lupus erythematosus, sarcoidosis, and pseudolymphoma, and we performed a punch biopsy. Histopathological examination of the biopsy revealed spindle-shaped myoid-appearing cells in a concentric arrangement, associated with thin-walled vascular channels with no mitotic activity or cytologic atypia [ Figure 2a and b]. Immunohistochemically, although the perivascular cells were focally positive for CD34 and CD31 for SMA, desmin was negative [ Figure 2c ]. After correlating clinical and histopathological findings and the immunohistochemical pattern, we diagnosed this lesion as myopericytoma. Because of complaints of ongoing pain in her scalp, she was referred to plastic surgery for total excision. There was no evidence of recurrence during 8 months of follow-up.
